Moffitt expert says study should put to rest fears of coffee increasing risk of most cancers. Read More

For cancer patients, anxiety and depression are associated with poor quality of life, lower survival rates and challenges with adhering to treatment. Read More

Exploring new approaches with immunotherapy, surgery. Read More

Both linked to higher risk of cancer. Read More

Promise Shown in Treating Acute Lymphoblastic Leukemia Read More

Moffitt partners with top cancer organizations to urge lawmakers to make HPV vaccination a priority. Read More

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer. Read More

Some cancer patients may be one step closer to being treated with cells from their own tumors. Read More

Moffitt’s closer look at clinical trial data could expand therapy’s use and effectiveness. Read More

More and more Americans are surviving cancer, and the number is expected to grow even larger in the next decade. Read More

Dozing off in front of the TV or sleeping with other lights on can affect your body’s metabolism and even lead to weight gain, according to a new study. Read More

Younger women battling advanced breast cancer may live longer by adding ribociclib to first-line endocrine therapy. Read More

Moffitt invites officials to learn from researchers and patients Read More

When artist Ray Paul was diagnosed with sarcoma in 2011, he wanted to better understand his disease. Read More

A low-fat, plant-based diet has been linked to a reduced risk of death from breast cancer. Read More

Last year, Lee was diagnosed with stage 4 metastatic lung cancer that had spread to her brain and spine. Read More

As Skin Cancer Awareness Month begins, Moffitt continues studies of deadliest form Read More

Data from Total Cancer Care® fuels research efforts. Read More

She leads a computational lab that models the mechanisms of interaction between tumors and their microenvironments Read More

Moffitt expert says obesity, drop in hysterectomies may account for rise Read More

Read More

Behind the scenes, the Luca Lab studies the "molecular language" of cell-to-cell communication using cutting edge approaches in structural, cellular and synthetic biology. Read More

Even though many people use the terms "antiperspirant" and "deodorant" interchangeably, antiperspirants are actually a subset of deodorants, and each works in a different way. Read More

Smokers hoping to crush out their last butt might consider weaning themselves off the habit with temporary help from e-cigarettes. Read More

Dr. Kosj Yamoah, a physician-scientist, tracks his roots of studying prostate cancer disparities through his native Ghana. Read More

Patients with certain fast-progressing and deadly types of acute myeloid leukemia (AML) saw the first new drug for their disease in more than 40 years approved by the FDA. Read More

The fourth one on the list of Moffitt research developments for 2017 involves rethinking drug resistance with a strategy called adaptive therapy that links the frequency, dosage and type of chemo to the tumor’s response. Read More

The third item on the list of Moffitt research developments for 2017 involves new targets for existing cancer-fighting drugs. Read More

The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More

The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More

Lung cancer is by far the leading cause of cancer death among both men and women. More than 220,000 Americans are diagnosed with lung cancer every year. Read More

What if a drug commonly used to protect bones from osteoporosis could be altered to keep out breast cancer cells? That’s the goal one Moffitt researcher is pursuing through the creation of "Smart Molecules." Read More

More than 30,000 pounds of medical and hurricane supplies, generators, food and water are on a chartered Boeing 737 headed for Puerto Rico, which was devastated by Hurricane Maria. Read More

Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More

Dr. Enderling is an assistant member in the Integrated Mathematical Oncology Department. Find out what his team accomplished at Miles for Moffitt this year. Read More

Dr. Doug Cress is an associate member of the Molecular Oncology Department. Learn more about his role in Molecular Oncology and the Spark Program. Read More

From caregivers to survivors and patients - more than 5,600 participants shared one common goal at Miles for Moffitt: raising funds for cancer research to save lives and ultimately defeat cancer. Read More

"We have all had loved ones who've been touched by cancer. I remember being struck by the huge quality of life burden that cancer patients and survivors face," says Dr. Gonzalez. Read More

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More

How does math coincide with cancer treatment? The answer lies within the Integrated Mathematical Oncology Department at Moffitt Cancer Center. Read More

The health care needs of LGBTQ patients who are at risk or fighting cancer are a priority for continued research, Moffitt Cancer Center’s Gwendolyn Quinn, PhD, and Matthew Schabath, PhD, told ResearchAmerica.org prior to World Cancer Day on Feb. 4. Read More

At Moffitt Cancer Center we look at every patient’s cancer as unique. Our clinical expertise and transformational research keeps us at the forefront of personalizing cancer care. Read More

After 12 years, a significant study at Moffitt has come to an end. Read More

Moffitt Cancer Center hosted a Cancer Moonshot Summit bringing together physicians, scientists, patients, and advocates to discuss viable ways to accelerate cancer research and improve treatment. Read More

May is National Cancer Research Month, which serves as an important reminder to everyone that the key to future progress in the fight against cancer lies in the critical work that still needs to be done. Read More

Moffitt Cancer Center and the American Association for Cancer Research (AACR) hosted the Cancer Research Policy Forum in the Ted Couch Auditorium on Monday, March 7. Read More

Moffitt Eager to Play Role in Biden's 'Moon Shot' to Cure Cancer Read More